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Cyclin-dependent kinase activation can prevent yeast cells from responding to mating 
pheromone. Strickfaden et al. (2007) now show that this block arises from the multisite 
phosphorylation of Ste5. This provides a beautiful example of how phosphorylation can 
produce decisive changes in protein function through bulk electrostatics, without the 
necessity of intricate conformational changes.Current thinking about the regulation of proteins by phos-
phorylation is dominated by allosteric regulation and con-
formational changes. The classic example is glycogen 
phosphorylase; when phosphorylated, it undergoes a dra-
matic reorganization that allows access of substrate to the 
otherwise buried catalytic site (Barford et al., 1991). Phos-
phorylation-driven conformational changes often involve 
the coordinated repositioning of multiple residues. These 
changes depend on subtle details of the folding energy 
landscape of the protein, and thus mutating or moving the 
phosphosite is rarely tolerated.
However, the consequences of protein phosphoryla-
tion can be much simpler. For example, the phosphoryla-
tion of a residue near the active site of isocitrate dehy-
drogenase inactivates the enzyme without inducing any 
conformational change; the phosphate simply blocks 
substrate binding (Hurley et al., 1990). Phosphorylation 
can also add function to a protein without a conformation 
change, as in the creation of SH2-binding epitopes by the 
phosphorylation of tyrosine.
A splendid example of a simple mechanism for trans-
ducing changes in phosphorylation state into changes 
in protein function is provided by recent work on the 
regulation of Ste5, a MAPK cascade scaffold protein 
critical for mating pheromone responses in S. cerevi-
siae. In this issue, Strickfaden and colleagues (2007) 
show that phosphorylation of a cluster of eight poorly 
conserved SP/TP residues near the polybasic mem-
brane-binding domain of Ste5 prevents binding to the 
inner leaflet of the plasma membrane and thence pre-
vents picking up an activation signal. This inhibition 
appears to arise from the electrostatic repulsion of the 
negatively charged plasma membrane lipids by these 
phosphorylated residues. The idea of regulating protein 
function through bulk electrostatics is highly appealing; 
in contrast to allostery, it seems simple, robust, and 
easy to evolve. In addition, the involvement of a large 
number of phosphorylation sites should allow for the 
generation of a decisive, ultrasensitive switch without a 
requirement for classical cooperativity.Regulation of Ste5 by Cln/CDK
Mating is initiated when a mating pheromone binds a G 
protein-coupled receptor on a haploid yeast cell. This 
causes the release of a Gβγ dimer from a trimeric G pro-
tein, which then recruits the Ste5 scaffold to the plasma 
membrane. This recruitment then promotes the activa-
tion of the MAPKKK Ste11 by the membrane-localized 
Ste20. Mutations that abolish membrane localization of 
Ste5 abolish signaling, and mutations that allow mem-
brane localization in the absence of Gβγ cause constitu-
tive signaling. However, the mating pheromone pathway 
is not always responsive to pheromone. The pathway is 
maximally responsive in G1-phase cells and becomes 
unresponsive once cells have activated Cln/CDKs and 
traversed START when cells commit to cell division 
(Oehlen and Cross, 1994; Wassmann and Ammerer, 
1997). The converse is also true; activation of the mat-
ing pathway prevents the cell from activating Cln/CDK 
complexes and entering S phase (Chang and Herskow-
itz, 1992).
The identification of Ste5 as an important Cln/CDK 
target comes from studies that examine how and when 
Ste5 is localized to the membrane (Strickfaden et al., 
2007; Winters et al., 2005). Winters and coworkers 
observed that an N-terminal peptide from Ste5 localizes 
constitutively to the membrane with or without pherom-
one present and in yeast lacking the Gβ subunit normally 
required for Ste5 recruitment. Molecular dissection of 
Ste5 revealed a crucial lysine- and arginine-rich stretch 
near the N terminus that partitions into the plasma mem-
brane. There is a striking dependence on the charge 
and density of the acidic phospholipids, suggesting 
that electrostatic interactions are important (Winters et 
al., 2005). The partitioning is strong enough to localize 
an N-terminal peptide fragment of Ste5 but insufficient 
to localize the full-length protein (Winters et al., 2005). 
Likewise, in the absence of the basic region, the affin-
ity of Ste5 for the receptor-activated Gβγ dimer is not 
enough to bring the scaffold to the membrane (Winters 
et al., 2005).Cell 128, February 9, 2007 ©2007 Elsevier Inc. 441
Strickfaden et al. (2007) now show that Ste5 is multiply 
phosphorylated by Cln/CDK at sites close to the basic 
region. These phosphorylations inhibit membrane bind-
ing and pheromone signaling by repelling the negatively 
charged lipids of the inner leaflet of the plasma mem-
brane. Thus, Ste5 is acting as an AND gate, or a coin-
cidence counter, requiring both an active Gβγ dimer to 
provide one increment of binding energy and a dephos-
phorylated basic region to provide another. Substituting 
the eight phosphorylation sites with glutamates yields a 
protein that has an impaired, but not completely blocked, 
response to pheromone (Strickfaden et al., 2007). One 
might suspect that the carboxylic acid only partially mim-
icked the allosteric role of the phosphoryl group, and under 
such circumstances, replacing the adjacent proline with 
an additional glutamate should only make matters worse. 
Strikingly, replacing the SPs and TPs with EE completely 
blocked the pheromone response, and further mutational 
analysis revealed that membrane binding depends on 
the number, but not the exact position, of the negative 
charges (Strickfaden et al., 2007). Therefore, Ste5 differs 
from glycogen phosphorylase in two fundamental and 
ultimately interconnected ways. First, glycogen phospho-
rylase requires only a single phosphorylation to dramati-
cally change the behavior of the protein, whereas each of 
the many phosphosites within Ste5 contributes fraction-
ally to the inhibition. Second, glycogen phosphorylase is 
allosterically regulated, whereas Ste5 is not.
The Electostatic Switch Model
In the mid-1990s, Stuart McLaughlin suggested an 
intriguing mode of phospho-dependent regulation that 
he called the myristoyl-electrostatic switch (McLaughlin 
and Aderem, 1995). He and others had shown that poly-
basic peptides would bind through coulombic attrac-
tion, albeit weakly, to acidic phospholipids (Ben-Tal et 
al., 1996). Furthermore, he observed that the MARCKS 
protein contains a cluster of basic residues that, in con-
junction with a myristate chain, provide enough binding 
energy to anchor the protein to the plasma membrane. 
Embedded within this basic region are three phosphor-
ylation sites and, upon phosphorylation, MARCKS falls 
off the membrane (Kim et al., 1994). A similar biophysi-
cal study with the myristoylated and basic N terminus 
of Src and a pair of phosphosites had the same out-
come (Murray et al., 1998). McLaughlin found that “the 
membrane association increases with a larger percent-
age of acidic lipid in the membrane, a greater number 
of basic residues in the peptide, and a reduction in the 
ionic strength, whereas it is independent of the chemical 
nature of both the basic residues and the acidic lipid.” 
These observations strongly suggest that the binding 
is due to nonspecific electrostatic attraction and that 
phosphorylation reduces the affinity by reducing the net 
positive charge of the peptide.
The net free energy of association of a modest mac-
romolecular interaction (Kd = 1 µM) is 8.3 kcal/mol. 
McLaughlin’s biophysical measurements indicate that 442 Cell 128, February 9, 2007 ©2007 Elsevier Inc.each phosphorylation lowers the equilibrium constant 
(Keq) by about a factor of 10, corresponding to ∆∆G of 
1.4 kcal (Murray et al., 1998). Thus, given that the elec-
trostatic repulsive force provided by the addition of two 
negative charges is small compared to the scale of most 
biologically meaningful binding energies, only the cumu-
lative effective of several phosphorylation sites will com-
pletely disrupt an interaction. In addition the location and 
primary structural context of the phosphosite, provided 
that it is close to the polybasic region, is relatively unim-
portant, and thus might be relatively easy to evolve.
The essential features of McLaughlin’s model are found 
prominently in the regulation of Ste5′s association with 
the plasma membrane. For Ste5, the role of myristoylation 
is played by the weak protein-protein interaction with the 
receptor-activated Gβγ dimer. The multisite phosphoryla-
tion of Ste5 first weakens the association of Ste5 with the 
membrane and then ultimately reverses it. If the McLaugh-
lin data apply, each Ste5 phosphorylation decreases the 
binding energy by (probably) about 1.4 kcal/mol.
Switch or Rheostat?
There are clear parallels between the regulation of Ste5 
as elucidated here and that of Sic1, a well-studied stoi-
chiometric inhibitor of CDKs (Nash et al., 2001). Both 
proteins are inhibited by CDK phosphorylation at multi-
ple poorly conserved sites. In addition, both are embed-
ded in double-negative feedback loops: Ste5 inhibits 
the activation of CDKs through Far1 and CDKs block 
Ste5 localization through phosphorylation; Sic1 inhibits 
CDKs stoichiometrically and CDKs inhibit Sic1 by trig-
gering its degradation. These systems could allow the 
cell to toggle between two mutually exclusive states. 
Bistable systems such as these are easiest to engineer 
if at least one leg of the double-negative feedback loop 
exhibits a switch-like, sigmoidal, ultrasensitive response 
to its upstream inhibitor. Sigmoidal responses can be 
generated through allostery in multisubunit cooperative 
enzymes. As Strickfaden et al. (2007) point out, multisite 
phosphorylation and bulk electrostatics might be a sim-
pler way of producing a qualitatively similar response.
There are also parallels between Ste5 and Ets1, a tran-
scription factor whose DNA binding is regulated by three 
clustered CaMKII phosphorylation sites. Each phosphor-
ylation in Ets1 successively decreases the affinity of Ets1 
for DNA, by about 0.4 kcal/mol (Pufall et al., 2005), less 
than that measured by McLaughlin and assumed here 
for Ste5. This occurs by shifting Ets1 from an autoinhib-
ited state to a DNA-binding state through bulk electro-
static interactions between the phosphorylated cluster 
and the DNA-binding ETS domain (Pufall et al., 2005). 
However, in this case, the regulation of Ets1 is said to 
resemble a rheostat, not a switch. There are other exam-
ples, such as the multisite phosphorylation of the Kv2.1 
potassium channel, which produces graded, additive 
changes in channel properties (Park et al., 2006). This is 
a conundrum. Does multisite phosphorylation and bulk 
electrostatics produce a graded response in some con-
Figure 1. Electrostatic Switches and 
Rheostats
(A) Schematic model of Ste5 phosphorylation 
and dephosphorylation. For simplicity we omit 
the interaction of Ste5 with Gβγ, as well as the 
interaction of Ste5′s PH domain with PIP2.
(B) Calculated steady-state levels of phos-
phorylation (blue lines) and membrane binding 
(red line) for Ste5. The dashed blue line as-
sumes no membrane binding. The solid lines 
assume that there is membrane binding and 
that the membrane shields Ste5 from kinases 
and phosphatases. Details of the modeling 
can be found as Supplemental Data.
(C) Heat map representation of the effective 
Hill coefficients for membrane binding as a 
function of the number of phosphorylation 
sites and the free energy increment produced 
by each phosphorylation. Hill coefficients are 
calculated based on the fold-change in kinase 
activity needed to drive the system from 90% 
membrane binding to 10% membrane binding 
by the formula
= log[81]
log[ 10 / 90]H
n
EC EC
For parameter choices that yielded maximum 
levels of binding of less than 90%, minimum 
levels of binding of more than 10%, or both, 
the Hill coefficients are depicted as “ND.” The 
map on the right assumes that the kinases and 
phosphatases act only on the free species, 
whereas the map on the left assumes that 
the enzymes act equally well on the free and 
bound forms. The expected Hill coefficients for 
Ste5 membrane binding and Ets1 DNA binding 
are indicated by stars.texts and a switch-like response in others? If so, what 
determines the qualitative character of the response?
To address this question we begin with a simple kinetic 
model of the phosphorylation and dephosphorylation of 
Ste5 at eight sites (Figure 1A). A system like this pro-
duces a switch-like, ultrasensitive response to changes 
in the concentration of active CDK only if the phospho-
rylation of the last few sites is more favorable than the 
phosphorylation of the first few (Gunawardena, 2005). 
This requirement is analogous to the concept of coop-
erativity in multisubunit, allosteric enzymes. So does the 
phosphorylation of Ste5 at the first few sites promote its 
phosphorylation at the last few?
In the absence of membrane binding, our guess is that 
it would not, based on simple combinatorics. There are 
eight ways to convert Ste5-0P (with no phosphoryla-
tions) to Ste5-1P and only one way to convert Ste5-7P 
to Ste5-8P, so that other things being equal, we would 
expect the effective rate constant for the first phospho-
rylation to be eight times that of the eighth. When the 
phosphorylation rate constants become successively 
smaller and the dephosphorylation rate constants suc-
cessively larger as phosphorylation increases, the result 
is that phosphorylation becomes a very graded function 
of kinase concentration (Figure 1B, dashed blue curve). 
Phosphorylation is a rheostat here.However, introducing membrane binding can dra-
matically change things. If one assumes that only free 
Ste5 can be phosphorylated and dephosphorylated, 
with membrane binding shielding Ste5′s phosphoryla-
tion sites from Cln/CDK and the relevant phosphatase, 
then as each phosphate is added to Ste5, there is suc-
cessively more and more free Ste5 available for phos-
phorylation. In this way, phosphorylation promotes more 
phosphorylation, and the result can be a highly switch-
like response (Figure 1B, solid blue line). The system now 
shifts from having most of the Ste5 hypophosphorylated 
to most of it hyperphosphorylated over a relatively nar-
row range of kinase concentrations (Figure 1B).
Some additional sharpening of the response arises 
because of the exponential dependence of binding 
constants on binding energy. Changing the phospho-
rylation state of Ste5 from, say, four phosphates to 
five increases the phosphorylation by only 1.25-fold 
but would be expected to change the membrane bind-
ing constant by 10-fold. This sharpens the response 
further still (Figure 1B, red line). A high Hill coefficient 
would be expected for Ste5 membrane binding as 
long as the number of phosphorylation sites involved 
is not much less than 8 and the change in binding con-
stant per phosphorylation is not much less than 10-
fold (Figure 1C, right).Cell 128, February 9, 2007 ©2007 Elsevier Inc. 443
So is Ets1 actually a rheostat in terms of binding 
energy but a switch in terms of binding constants? Prob-
ably not. The degree of ultrasensitivity produced by bulk 
electrostatics depends both on the amount of binding 
energy produced (or taken away) by each phosphoryla-
tion and also on the number of sites. For the number of 
sites (3) and the amount of binding energy (0.4 kcal/mol) 
measured for Ets1, the protein acts like a rheostat, not a 
switch (Figure 1C, left).
Evolutionary Plasticity
Phosphorylation sites are frequently found in regions 
of proteins predicted to be unstructured (Dunker et al., 
2002), which are often poorly conserved (Brown et al., 
2002). Both observations are at odds with an allosteric 
model of phosphorylation but are consistent with mech-
anisms employing bulk electrostatic properties. Even 
though Ste5 homologs in Ashbya gossypii and Kluyvero-
myces lactis have less than 30% identity with S. cerevi-
siae Ste5, helical wheels anchored by a conserved basic-
basic-W-T-E motif reveal basic and hydrophobic faces. In 
all three proteins, the regions on either side of the basic 
stretch do contain an abundance of SP and TP motifs, 
though their positions vary widely, supporting the notion 
that position is relatively unimportant. In principle both 
the binding affinity and the cooperativity of a response to 
kinase activity in these multiply phosphorylated proteins 
can be fine-tuned through the straightforward evolution-
ary emergence or disappearance of phosphosites.
The loose spatial requirements of the phosphosites 
may also allow for overlapping regulation by different 
upstream kinases. David Morgan’s group has recently 
shown that the kinases Ime2 and Cdk1 have different 
optimal peptide substrate specificities, but nonetheless 
both phosphorylate an overlapping set of substrates. 
Cdh1, for example, has 11 consensus CDK sites and 5 
distinct consensus Ime2 sites, and phosphorylation by 
either kinase inhibits Cdh1’s ability to activate the APC 
(D. Morgan, personal communication). The reliance on 
multiple spatially distributed phosphosites suggests a 
mechanism akin to the electrostatic switch.
Recently our group has been studying the control of 
another important cell-cycle regulator, Wee1, by multisite 
phosphorylation. Like Ste5, Wee1 is phosphorylated at 
several poorly conserved CDK sites. In this case, these 
sites appear not to function as an electrostatic switch 
but rather to buffer the activity of Cdk1, generating 
ultrasensitivity through a competition mechanism (Kim 
and J.E.F., unpublished data). As with the electrostatic 
model, the structure and local sequence surrounding 
the phosphosites in this competition model need not be 
rigidly defined.
Final Word
Ste5 has provided the field of protein regulation with a 
strikingly large number of important insights down through 
the years, contributing to our ideas of signaling scaffolds 
(Choi et al., 1994), docking domains (Kusari et al., 2004), 444 Cell 128, February 9, 2007 ©2007 Elsevier Inc.and enforced proximity (Park et al., 2003), among others. 
All of these concepts are widely appreciated to apply to 
virtually all signaling pathways. Now Ste5 has provided a 
beautiful example of how multisite phosphorylation can 
be read out via bulk electrostatic effects to yield a pow-
erful biochemical switch (Strickfaden et al., 2007). Post-
translationally tuned bulk electrostatics provides a simple 
and effective alternative to allostery for regulating protein 
function. We suspect that this too will prove to be a recur-
ring theme in protein regulation.
Supplemental Data
Supplemental Data include details of the modeling and can be found with 
this article online at http://www.cell.com/cgi/content/full/128/3/441/DC1/.
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